CV Sciences (0HRT) Stock Statistics & Valuation Metrics
Total Valuation
CV Sciences has a market cap or net worth of $1.92M. The enterprise value is $5.97M.
- Market Cap
- $1.92M
- Enterprise Value
- $5.97M
Share Statistics
CV Sciences has 225,829,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 225,829,130
- Owned by Insiders
- 11.80%
- Owned by Institutions
- <0.01%
Financial Efficiency
CV Sciences’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -28.58%.
- Return on Equity (ROE)
- -0.65
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -28.58%
- Return on Capital Employed (ROCE)
- -0.51
- Revenue Per Employee
- 320.67K
- Profits Per Employee
- -22.28K
- Employee Count
- 43
- Asset Turnover
- 1.98
- Inventory Turnover
- 1.72
Valuation Ratios
The current PE Ratio of CV Sciences is -0.96. CV Sciences’s PEG ratio is 0.02.
- PE Ratio
- -0.96
- PS Ratio
- 0.18
- PB Ratio
- 1.31
- Price to FCF
- -4.33
- Price to Operating Cash Flow
- -4.17
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, CV Sciences had revenue of 13.79M and earned -958.00K in profits. Earnings per share was -0.01.
- Revenue
- 13.79M
- Gross Profit
- 6.75M
- Operating Income
- -992.00K
- Pretax Income
- -949.00K
- Net Income
- -958.00K
- EBITDA
- -562.00K
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -492.00K and capital expenditures -30,000, giving a free cash flow of -522.00K billion.
- Operating Cash Flow
- -492.00K
- Free Cash Flow
- -522.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
CV Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -23.11%
- Earnings Yield
- -97.81%
Stock Price Statistics
- Beta
- -0.39
- 52-Week Price Change
- -60.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
CV Sciences upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
CV Sciences as a current ratio of 1.03, with Debt / Equity ratio of 109.60%
- Current Ratio
- 1.03
- Quick Ratio
- 0.21
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- -2.37
- Interest Coverage Ratio
- -1.92
Taxes
In the past 12 months, CV Sciences has paid 9,000 in taxes.
- Income Tax
- 9,000
- Effective Tax Rate
- -0.01
Enterprise Valuation
CV Sciences EV to EBITDA ratio is -2.44, with an EV/FCF ratio of -6.22.
- EV to Sales
- 0.25
- EV to EBITDA
- -2.44
- EV to Free Cash Flow
- -6.22
- EV to Operating Cash Flow
- -6.60
Balance Sheet
CV Sciences has $266.00K in cash and marketable securities with $1.25M in debt, giving a net cash position of -$987.00K billion.
- Cash & Marketable Securities
- $266.00K
- Total Debt
- $1.25M
- Net Cash
- -$987.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 49.14%, with operating margin of -11.70%, and net profit margin of -15.74%.
- Gross Margin
- 49.14%
- Operating Margin
- -11.70%
- Pretax Margin
- -15.69%
- Net Profit Margin
- -15.74%
- EBITDA Margin
- -10.43%
- EBIT Margin
- -11.70%
Analyst Forecast
The average price target for CV Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -14.90%
- EPS Growth Forecast
- -22.35%